Pregnancy registry
Safety of IL-17 and IL-23 inhibitors as treatment for immune mediated inflammatory diseases at conception and during pregnancy: an ENTIS study. (SAFE-PPREG)
Belgium
France
Germany
Ireland
Israel
Italy
Netherlands
Switzerland
United Kingdom
EU PAS number:
EUPAS1000000960
First published:
26/03/2026
Study
Ongoing
Vyepti Pregnancy Registry: A prospective, comparative cohort study of maternal, fetal and infant safety in pregnant women exposed to eptinezumab in the United States
United States
EU PAS number:
EUPAS1000000936
First published:
19/02/2026
Study
Ongoing
Estimation of background incidence rates of coagulation disorders and the association with COVID-19 vaccines in pregnant population: a multi-database study from 3 European countries
Denmark
Finland
Italy
Netherlands
Spain
EU PAS number:
EUPAS1000000918
First published:
06/03/2026
Study
Planned
The Eplontersen Pregnancy and Lactation Outcomes Study: A Descriptive Safety Study of Pregnant and Lactating Individuals and Their Offspring Exposed to Eplontersen (EPPRO)
Argentina
Armenia
Australia
Austria
Belgium
Brazil
Bulgaria
Canada
China
Croatia
Czechia
Denmark
Estonia
European Union
Finland
France
Georgia
Germany
Greece
Greenland
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Korea, Democratic People's Republic of
Latvia
Lithuania
Luxembourg
Netherlands
New Zealand
Norway
Other
Poland
Portugal
Romania
Singapore
South Africa
Spain
Sweden
Switzerland
Türkiye
Ukraine
United Arab Emirates
United Kingdom
United Kingdom (Northern Ireland)
United States
EU PAS number:
EUPAS1000000736
First published:
24/03/2026
Study
Planned
A Post-Marketing Safety Study to Evaluate the Safety of VELSIPITY® (Etrasimod) Exposure During Pregnancy (C5041043)
Canada
United States
EU PAS number:
EUPAS1000000672
First published:
03/09/2025
Study
Planned
BRIUMVI® Pregnancy Registry: A Prospective Study of Pregnancy and Infant Outcomes in Patients Treated with BRIUMVI®
United States
EU PAS number:
EUPAS1000000614
First published:
08/10/2025
Study
Ongoing
I8F-MC-B016 Tirzepatide Pregnancy Registry - A Multi-Country Registry-Based Observational Study to Assess Maternal, Fetal, and Infant Outcomes Following Treatment with Tirzepatide for Weight Management During Pregnancy
Germany
United Kingdom
United States
EU PAS number:
EUPAS1000000517
First published:
14/01/2026
Study
Planned
Prospective, Registry-Based Observational Cohort Study of Zavegepant Safety in Pregnancy
United States
EU PAS number:
EUPAS1000000335
First published:
12/06/2025
Study
Planned
A Post-marketing, Observational, Descriptive Study to Assess the Risk Associated With Pregnancy, the Maternal Complications and Adverse Effects on the Developing Fetus, Neonate, and Infant Among Individuals Exposed to Omaveloxolone During Pregnancy and/or Lactation
United States
EU PAS number:
EUPAS1000000327
First published:
14/02/2025
Study
Planned
Nested case-control study evaluating effectiveness of immunization of girls and women of childbearing potential with GARDASIL(TM)/GARDASIL(TM) 9 against juvenile-onset recurrent respiratory papillomatosis (JoRRP) in Sweden, Denmark, and Norway (V503-095)
Denmark
Norway
Sweden
EU PAS number:
EUPAS1000000286
First published:
26/11/2025
Study
Ongoing